UCB - Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
Alcon AG USD 1.68B 16M 2026-06
Almirall EUR 429.87M 180.02M 2025-12
Amarin USD 23.17M 961K 2025-12
argenx SE USD 1.18B 40.98M 2026-03
AstraZeneca USD 12.86B 251M 2026-06
Bayer EUR 6.33B 1.84B 2026-06
Genmab DKK 1.07B 240M 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
GRIFOLS EUR 704M 84M 2026-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Lakefront Biotherapeutics EUR 1.68M 898.68M 2026-03
Lonza CHF 1.29B 248M 2025-06
Merck EUR 3.17B 101M 2026-06
Novartis USD 11.24B 1.18B 2026-06
Orion EUR 339.9M 85.9M 2026-06
Recordati EUR 497.97M 12.85M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.71B 602M 2026-06
UCB EUR 3.19B 621M 2025-12
Unibail Rodamco EUR 997M 516.9M 2024-12